Pernicious Anemia and Subacute Combined Degeneration

by

Pernicious Anemia Is a Neurological Disease

I. Pernicious Anemia Is a Demyelinating Neurological Disease

Pernicious anemia (PA) is an autoimmune disorder in which vitamin B12 cannot be adequately absorbed or utilized, leading to progressive neurological injury.

Autoimmune failure of vitamin B12 absorption disrupts methylation and fatty acid metabolism essential for myelin maintenance and repair, producing central and peripheral demyelination, tract-specific spinal cord injury (classically subacute combined degeneration), and widespread cognitive, emotional, and psychiatric manifestations. These neurological effects frequently precede anemia and may occur in its absence.

Pernicious anemia (PA) typically has an insidious onset, with early symptoms that are nonspecific and easily misattributed. As a result, diagnosis is often delayed several years from symptom onset to receive a correct diagnosis, and a substantial proportion are initially misdiagnosed or not diagnosed at all. During this period, neurological injury continues to accumulate. Clinicians are therefore often faced with patients who already have advanced neural involvement by the time the underlying disorder is recognized.

Because myelin repair is metabolically demanding and time-dependent, outcomes depend not only on correcting cellular B12 deficiency but on interacting system constraints rather than hematologic markers alone.

Understanding how this injury unfolds, and why its effects vary so widely, requires looking beyond any single pathway.

II. Understanding Pernicious Anemia Requires a Systems-Level Frame

Medical research excels at isolating mechanisms and correcting discrete deficiencies. Pernicious anemia operates at a higher level of biological organization. Its pathology spans molecular processes, cellular metabolism, tissue integrity, and network-level neural function unfolding over time.

Individual mechanisms can be described precisely, yet the lived course of the disease reflects interactions among those mechanisms rather than any single failure in isolation. Demyelination in an adult nervous system occurs under conditions shaped by prior injury, metabolic stress, and limited repair capacity. Understanding PA therefore requires integrating validated mechanisms into a coherent systems-level picture.

At the center of this system-level disease is a specific upstream failure that drives all downstream effects.

III. B12 Malabsorption

Pernicious anemia most often begins with autoimmune destruction of gastric parietal cells, leading to intrinsic factor deficiency and impaired vitamin B12 absorption. Multiple autoimmune mechanisms beyond classic gastritis have also been identified, but the functional outcome is the same: vitamin B12 cannot be adequately utilized within cells.

This is an intracellular deficiency. Serum B12 levels may appear normal or even elevated while tissues—particularly nervous tissue—remain functionally deficient. Standard laboratory measures often obscure the failure.

This upstream constraint does not fluctuate with effort, diet quality, or motivation. It establishes the conditions under which all downstream neurological effects unfold.

The consequences of this intracellular deficiency are felt most acutely in tissues with the highest metabolic and structural demands.

IV. The Nervous System Is a Primary Target

Vitamin B12 is required for two biochemical functions that are especially critical to nervous tissue: methylation reactions and fatty acid metabolism. Both are foundational to maintaining myelin integrity.

Neurons and oligodendrocytes operate under uniquely demanding conditions. They are long-lived cells with limited capacity for replacement, high energy requirements, and little redundancy. Myelin synthesis and maintenance are metabolically expensive processes that depend on uninterrupted biochemical support. When B12 availability drops, nervous tissue cannot pause or compensate. Damage accumulates.

When these pathways fail, toxic metabolites accumulate. Methylmalonic acid builds up from impaired fatty acid metabolism, and homocysteine accumulates when methylation is disrupted. Both are directly neurotoxic and destabilize nerve structure and function, compounding injury beyond impaired myelin synthesis alone.

Blood cells, by contrast, turn over rapidly and can mask deficiency for long periods. This difference explains why neurological injury commonly precedes anemia and may occur without it.

When these biochemical supports fail, the resulting injury follows a characteristic pattern within nervous tissue.

V. Demyelination Is the Central Injury Pattern

Myelin is not passive insulation. It is a timing structure. By regulating conduction velocity and synchronizing signal transmission across circuits, myelin enables coordinated movement, sensation, cognition, and emotional regulation.

Demyelination disrupts this timing. Signals arrive late or out of sequence. Networks lose coherence. The result is not a single symptom but a pattern of failures across systems that depend on precise coordination.

This injury pattern is most clearly illustrated in the characteristic spinal cord involvement seen in pernicious anemia.

VI. Subacute Combined Degeneration: The Signature Expression

The most classically described manifestation of demyelination in PA is subacute combined degeneration of the spinal cord. This involves characteristic injury to the dorsal columns and lateral corticospinal tracts.

Damage to the dorsal columns impairs proprioception and vibration sense, producing sensory ataxia and imbalance. Involvement of the corticospinal tracts leads to weakness, spasticity, and gait disturbance. Together, these findings provide a clear anatomical map of demyelinating injury.

Subacute combined degeneration is the archetype, not the boundary, of neurological involvement. Demyelination extends beyond these tracts to peripheral nerves and cerebral white matter, producing a broader spectrum of effects.

Demyelination causes nerve damage that extends beyond motor and sensory pathways to affect cognition, mood, and perception.

VII. Neuropsychiatric and Cognitive Manifestations as Core Outcomes

Psychiatric and cognitive symptoms are primary symptoms of pernicious anemia.

Depression, anxiety, cognitive impairment, and emotional instability are common presentations of PA. In some individuals, these are the earliest or only manifestations. Severe deficiency can produce psychosis or schizophrenia-like syndromes.

These effects are often misdiagnosed as primary psychiatric illness. Emotional regulation, executive function, and perception depend heavily on timing-dependent neural networks and white-matter integrity. When myelin is compromised, these systems destabilize early.

Seen through this lens, psychiatric and cognitive symptoms are not secondary complications. They are expected consequences of demyelination affecting networks responsible for affect, attention, and integration.

These diverse manifestations reflect disruption of neural networks whose function depends on intact myelin.

VIII. Myelin Status Constrains Recovery

Myelin is a lipid-dense, protein-structured membrane produced by oligodendrocytes in the central nervous system and Schwann cells in the periphery. Its synthesis requires substantial energy, precise coordination, and a steady supply of multiple substrates.

Adult remyelination differs fundamentally from developmental myelination. It occurs in an environment shaped by prior injury, inflammation, and metabolic stress. Repair is therefore slower, less complete, and highly time-dependent.

Once injury is established, the limits of recovery are set by the biological requirements of myelin repair rather than by the simple correction of B12 deficiency.

IX. Myelin Repair as a Systems Problem

Repairing myelin is not a single-step process. Myelin synthesis and maintenance depend on the coordinated function of multiple metabolic systems operating simultaneously. When any one system becomes limiting, repair slows or fails even if upstream deficiencies have been corrected.

A. Lipid Architecture of Myelin

Myelin is composed predominantly of specialized lipids, including very-long-chain fatty acids, sphingolipids, phospholipids, and cholesterol arranged in a compact structure. These lipid classes are not interchangeable.

Very-long-chain fatty acids contribute directly to membrane thickness and electrical insulation. Cholesterol is essential for membrane compaction and durability. In the central nervous system, cholesterol must be synthesized locally by oligodendrocytes because peripheral cholesterol does not cross the blood–brain barrier in meaningful amounts.

These requirements make myelin repair metabolically demanding and locally constrained.

B. Protein Synthesis and Methylation-Dependent Regulation

Myelin structure depends on myelin basic protein and proteolipid protein, which organize lipid layers and maintain compaction.

Oligodendrocyte differentiation and myelin gene expression are regulated by methylation-dependent processes. Vitamin B12 supports this regulatory capacity through its role in methionine metabolism. When methylation is impaired, myelin components may be present but improperly coordinated, limiting effective repair.

C. Other Vitamin Roles in Myelin Repair

Folate and vitamin B6 support the broader methylation cycle governing gene expression and cellular differentiation. Vitamin B1 supports the energy metabolism required for membrane synthesis. Vitamin D influences oligodendrocyte maturation and immune signaling. Vitamin E protects newly formed lipid membranes from oxidative damage.

These vitamins enable regulatory, metabolic, and protective processes necessary for repair.

D. Mineral Requirements for Oligodendrocyte Function

Iron supports energy metabolism and enzymes required for lipid and cholesterol synthesis. Copper and zinc act as cofactors for enzymes involved in cellular respiration, antioxidant defense, and protein stability. Disruption of these mineral-dependent pathways can impair myelin integrity.

E. Oxidative Stress Containment and Inflammatory Interference

Myelin is approximately seventy percent lipid by dry weight, making it inherently vulnerable to oxidative damage. During remyelination, newly forming membranes are especially fragile.

Elevated oxidative stress can damage myelin as it is being assembled, creating a ceiling on repair independent of substrate availability. Inflammation increases oxidative burden and interferes with oligodendrocyte differentiation, further constraining repair.

These repair requirements are shaped by broad physiological and environmental influences.

X. Modifiers of Injury and Recovery

Immune tone, inflammatory signaling, metabolic efficiency, sleep, stress physiology, and the gut microbiome all modulate how demyelination expresses itself and how recovery unfolds.

Variation in these influences explains why similar diagnoses can follow very different clinical courses.

XI. Optimization Requires System-Level Context

Discussions of optimization often focus on specific formulations or molecular preferences. This framing assumes universal levers.

In biological systems, optimization is contextual. Outcomes depend on which constraint is limiting at a given time. Timing and adequacy dominate outcomes more than fine distinctions between inputs.

These constraints make timing a central determinant of outcome.

XII. Clinical Reality: Timing Sets the Ceiling

Early correction of B12 deficiency offers the greatest potential for neurological improvement. Delayed treatment allows demyelination to progress and limits the degree of repair that remains possible.

Laboratory normalization does not equate to neural normalization. Persistent symptoms after treatment reflect biological limits rather than noncompliance or effort.

Maximum recovery from pernicious anemia–related neurological damage is constrained by the timing and biology of myelin repair.

XIII. Pernicious Anemia Reveals the Essential Challenge

Pernicious anemia illustrates a broader challenge in how chronic neurological illness is best understood and addressed at the systems level. Discrete mechanisms can be identified and corrected, yet disease unfolds through interacting constraints over time.

Seeing PA clearly—as a demyelinating neurological disease shaped by system-level biology—returns coherence to patient experience and clinical expectation alike.

References

Beaudry-Richard, A., Abdelhak, A., Saloner, R., et al. (2025). Vitamin B12 levels association with functional and structural biomarkers of central nervous system injury in older adults. Annals of Neurology, 97, 1190–1204. https://doi.org/10.1002/ana.27200

Froese, D. S., & Gravel, R. A. (2019). Vitamin B12, folate, and the methionine remethylation cycle—biochemistry, pathways, and regulation. Journal of Inherited Metabolic Disease, 42(4), 673–685. https://doi.org/10.1002/jimd.12009

Grabowska, M., Wawrzyniak, D., Rolle, K., Chomczyński, P., Oziewicz, S., Jurga, S., & Barciszewski, J. (2024). Vitamin B12 metabolism: A network of multi-protein mediated processes. International Journal of Molecular Sciences, 25(15), 8021. https://doi.org/10.3390/ijms25158011

Kumar, N. (2006). Copper deficiency myelopathy (human swayback). Mayo Clinic Proceedings, 81(10), 1371–1384.

Multiple Autoimmune Mechanisms Beyond Classic Gastritis. (n.d.). Red, Blue & Real. https://dittany.com/multiple-autoimmune-mechanisms-beyond-classic-gastritis/

Pernicious Anaemia Society. (2025, January). Symptoms. https://pernicious-anaemia-society.org/symptoms/

Saher, G., & Stumpf, S. K. (2015). Cholesterol in myelin biogenesis and hypomyelinating disorders. Biochimica et Biophysica Acta – Molecular and Cell Biology of Lipids, 1851(8), 1083–1094. https://pmc.ncbi.nlm.nih.gov/articles/PMC6844833/

StatPearls. (2023). Pernicious anemia. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK540989/

Systematic review/meta-analysis. (2024). Copper deficiency myelopathy mimicking cervical spondylitic myelopathy: A systematic review of the literature with case report. Clinical Neurology and Neurosurgery. https://www.sciencedirect.com/science/article/abs/pii/S1529943024002985

Wanjiku, G., Mwaniki, L., & Parker, R. (2025). Neurological manifestations of pernicious anaemia without macrocytic anaemia: A case report. Journal of Medical Case Reports, 19, 259. https://jmedicalcasereports.biomedcentral.com/articles/10.1186/s13256-025-05149-7

56-025-05149-7